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The development of matrix-assisted laser desorption/ionization (MALDI) mass spectrometry 
and its demonstrated performance with large proteins has generated substantial interest in 
utilizing this technique as an alternative to gel electrophoresis for DNA sequence analysis. 
However, a lack of understanding of the desorption and ionization processes has greatly 
hampered advances in this field. This article explores the formation of positively charged 
oligonucleotides in UV (355-nm) MALDI analysis by using the matrix 2,5-dihydroxybenzoic 
acid. Whereas ubstantial fragmentation is observed in the positive-ion mode by using the 
short oligomer d(TAGGT), no fragmentation is evident in the negative-ion mode under 
identical conditions. The fragmentation products are consistent with a previously published 
model in which base protonation i itiates base loss, which leads to subsequent cleavage of 
the phosphodiester backbone. Several polydeoxythymidilic acids containing modified nucle- 
osides were used to investigate positive-ion formation. The results support he hypothesis 
that positive ions are formed by protonation of the nucleobases. Because base protonation 
initiates base loss, fragmentation is intrinsic to positive-ion formation in the MALDI analysis 
of oligonucleotides. This result explains the dramatic difference in fragmentation bserved in 
positive-ion compared to negative-ion UV-MALDI mass spectra of oligonucleotides. © 1997 
American Society for Mass Spectrometry (J Am Soc Mass Spectrom 1997, 8, 218-224) 
T 
he development of matrix-assisted laser desorp- 
tion/ionization (MALDI) mass spectrometry and 
its demonstrated performance with large pro- 
teins, up to 300,000 u, has generated substantial inter- 
est in utilizing this technique for the analysis of DNA 
sequence [1]. MALDI for the analysis of intact protein 
molecules was first demonstrated by Karas et al. [2] 
and Tanaka et al. [3]. Since this discovery, MALDI has 
rapidly evolved into a powerful tool for the characteri- 
zation of a variety of biopolymers including proteins, 
peptides, and oligosaccharides. Although the MALDI 
analysis of proteins and peptides has enjoyed great 
success, the applicability of MALDI to oligonucleotides 
has been more limited due in part to the greater 
fragility of DNA. 
Unlike peptides, which are usually analyzed in the 
positive-ion mode, oligonucleotides are typically ana- 
lyzed in the negative-ion mode [4]. Nevertheless, posi- 
tive-ion MALDI spectra of oligonucleotides have been 
reported in the literature by several groups [5-7]. 
Results from Wu et al. [8], which displayed ecreasing 
ratios of positive- to negative-ion signals with increas- 
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ing oligomer size when measured in a reflecting time- 
of-flight (TOF) system, indicated that positive ions of 
oligonucleotides suffer from more fragmentation than 
negative ions. 
Zhu et al. [9] studied oligodeoxynucleotide frag- 
mentation i the negative-ion mode. This study showed 
that fragmentation is both sequence and matrix depen- 
dent. Based on the relative intensities of the observed 
fragmentation products, Zhu et al. compared fragmen- 
tation propensities of the four nucleosides. The results 
supported a mechanism for oligonucleotide fragmenta- 
tion in the MALDI process [9] in which protonation of
the nucleobases initiates base loss, which is followed 
by phosphate backbone cleavage. A similar oligonu- 
cleotide fragmentation mechanism was proposed by 
Nordhoff and co-workers [10, 11]. 
Other studies have focused on the ionization pro- 
cess, which is not yet well understood. Mowry et al. 
[12] demonstrated that matrix absorption of laser en- 
ergy results in the ejection of both neutral and charged 
matrix and analyte species. They found that matrices 
that produced strong analyte signals also produced 
large amounts of neutral analyte molecules in the gas 
phase. Ratios of analyte neutrals to ions were generally 
more than 10,000 to 1 at the threshold laser irradiance. 
Ehring et al. [13] investigated the ionization of many 
Received August 27, 1996 
Revised October 23, 1996 
Accepted October 23, 1996 
J Am Soc Mass Spectrom 1997, 8, 218-224 UV-MALDI OF OLIGONUCLEOTIDES 219 
organic molecules during the MALDI process and pro- 
posed that photoionized matrix molecules erved as 
agents for chemical ionization of the analyte molecules. 
Similarly, Russell et al. [14] suggested that analyte ions 
were formed by proton transfer eactions between the 
analyte and electronically excited matrix molecules. 
Interestingly, results from Nelson et al. [15] suggested 
that matrix ions might not be directly responsible for 
the ionization of analytes, but matrix-related ions that 
are initially generated uring or immediately after 
laser irradiation could be. 
Currently, the most successful matrix for nucleic 
acid analysis is 3-hydroxypicolinic a id (3-HPA) [8]. 
However, three major problems exist for the use of 
3-HPA as a matrix for nucleic acid analysis: (1) The 
largest mixed-base, single-stranded oligonucleotide an- 
alyzed is still only 89 nucleotides in length [8]; signals 
have been reported for longer strands up to 500 base 
pairs; however, these results were obtained from dou- 
ble-stranded DNA samples and suffered from ex- 
tremely low resolution [16]. (2) A substantial decrease 
in signal intensities is observed for higher molecular 
weight components in mixtures of oligonucleotides [1, 
8]. (3) Strong doubly charged analyte peaks have been 
reported that could affect peak identification in mix- 
ture analysis [8, 17]. Thus, substantial improvement in
the MALDI process is still needed for the analysis of 
single-stranded nucleic acids. 
Two possible reasons for the limitation in mass 
range observed by using 3-HPA are (1) poor incorpora- 
tion of long single-stranded DNA molecules into the 
matrix crystal structure and/or  (2) higher levels of 
fragmentation for longer DNA strands. Evidence in the 
literature suggests that matrix-specific incorporation 
effects may be significant because longer oligomers of 
fragmentation resistant polythymidilic acid are de- 
tected with higher efficiency by using 2,5-dihydroxy- 
benzoic acid (2,5-DHBA) than by using 3-HPA [17]. 
Unfortunately, the susceptibility of the other three 
nucleotides to fragmentation limits the analysis of their 
homopolymer oligonucleotides and mixed-base se- 
quences longer than 10 nucleotides in 2,5-DHBA [7, 9, 
181. 
Because base loss is observed by using 3-HPA as a 
matrix, the limited mass range observed with 3-HPA 
has also been attributed to fragmentation, i  spite of 
the fact that backbone cleavage products are not ob- 
served in the spectra [8, 11]. It is unclear at this point 
whether this result reflects a lack of backbone cleavage 
or a lack of ionization and hence detection of the 
cleavage products in 3-HPA (loss of a charged nucle- 
obase from a fragment ion yielding a neutral fragment 
would preclude its detection in both ion modes; such 
charged nucleobased ion signals are difficult o discern 
because they are buried in the abundant matrix signals 
present in the lower mass region of the spectra). As 
identical fragmentation products are observed for 
mixed-base, single-stranded oligonucleotides in vari- 
ous other matrices uch as 2,5-DHBA, {x-cyano-4-hy- 
droxycinnamic acid (HCCA), sinapinic acid (SA), and 
2,4,6-trihydroxy acetophenone (THAP) [19], it may be 
inferred that the same fragmentation mechanism, con- 
sisting of base loss followed by backbone cleavage, is 
likely to be operative in all four of these matrices. This 
mechanism ay also occur in 3-HPA because base loss 
is observed in MALDI spectra by using 3-HPA as the 
matrix [8, 11]. The present study uses 2,5-DHBA as a 
model system to help understand how differences in 
the chemical structure of oligonucleotides can affect 
protonation and fragmentation during the UV-MALDI 
process. 
In the MALDI process, negative ions are generally 
thought o originate through the abstraction of protons 
from the phosphodiester backbone, whereas positive 
ions are hypothesized to result from protonation of the 
nucleobases. However, experimental evidence support- 
ing these hypotheses i  minimal. Based on the different 
ability of various nucleosides to form positive ions, the 
presence of a suitable protonation site on the nucle- 
obase is shown here to be essential for efficient posi- 
tive-ion formation. Because nucleobase protonation is
the initiating step in the backbone fragmentation path- 
way [9, 10], the results indicate that the extensive 
fragmentation occurring in positive-ion mode is a di- 
rect consequence of positive-ion formation. The use of 
modified bases, which provide protonation sites but 
are resistant to fragmentation, permits analysis of 
oligonucleotides in positive-ion mode without frag- 
mentation. These results are consistent with previous 
work elucidating the fragmentation pathway and pro- 
vide insight into the likely ionization sites of both 
positive and negative oligonucleotide ions in MALDI. 
Experimental 
Oligodeoxynucleotides d(TAGGT), d(T) 5, d(T)12, 
d(T4T*T7), d(T4CAraT7 ), d(T4CAra4T7) , d(T4CT7), 
d(T4C2T7), d(T4C4T7), d(T4CT3T*T3), d(T4C2T3T*T3), 
d(T4C4T3T*T3 ), d(T3T*CT3T*T3), d(T3T*TgCT*T3), 
d(T6T*CT*T3), and d(TBT*CT*T 6) were synthesized by 
the University of Wisconsin Biotechnology Center on 
an Applied Biosystems 394 DNA synthesizer. The 
thymidine analog dT* has the C-5 methyl group on its 
nucleobase substituted by a but-2-enoic acid (2- 
amino-ethyl)-amide. The modified cytidine nucleoside 
C Ara has an arabinose rather than a ribose sugar ring 
because of inversion of the hydroxyl group at the 2' 
position of the sugar. Chemical structures of dT* and 
cAra are shown in Figure 1. The modified nucleosides 
were incorporated into synthetic oligonucleotides by 
using the phosphoramidate d rivatives (amino-mod- 
ifier C2 dT, #10-1037-90, and ara-cytidine, #10-4010-90, 
respectively; Glen Research, Sterling, VA). Oligonu- 
cleotide sequences are written in the 5' to 3' direction. 
All of the oligodeoxynucleotide samples except for the 
modified ones were prepared with dimethoxytrityl 
(DMT) groups at their 5' termini enabling sample 
purification by using C18 Sep-Pak cartridges (Waters 
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Figure 1. Chemical structures for (a) thymidine analog dT* 
(MW 340.33 u) and (b) modified cytidine nucleoside C Ara (MW 
243.22 u). 
Chromatography, Milford, MA) as described previ- 
ously [9]. Modified oligodeoxynucleotides (T4C AraT7) , 
d(T4C Ara4T7) , d(T4CT3T*T3) , d(T4C 2TBT*T3), 
d(T4C4T3T*T3), d(T3T*CTBT*T3), d(T3T*T3CT*T3), 
d(T6T*CT*T3) , and d(T3T*CT*T6) were purified via 
high performance liquid chromatography (HPLC) on a 
C18 reversed-phase (5-/xm × 25-cm column 86-203-C5, 
Rainin Instrument Co., Inc., Woburn, MA) HPLC sys- 
tem (Shimadzu SIL-6A, Shimadzu Corporation, Kyoto, 
Japan). Solvents and gradients used in the HPLC pu- 
rification have been described previously [9]. Concen- 
trated stock solutions of each purified oligonucleotide 
were stored at -20 °C. 
Saturated solutions of 2,5-dihydroxybenzoic a id 
(2,5-DHBA) and 3-hydroxypicolinic a id (3-HPA) (Al- 
drich Chemical Co., Milwaukee, WI) were prepared in 
9:1 and 1:1 mixtures of water and acetonitrile. Matrix 
solutions were treated overnight with a cation-ex- 
change resin to remove alkali cations. The cation-ex- 
change resin used was in the ammonium form and 
was generated from the hydrogen form of AG 50W-X8 
(200-400 mesh) BioRad Laboratory, Richmond, CA) 
following procedures described elsewhere [20]. 
All spectra were collected by using a Vestec (Hous- 
ton, TX) model VT 2000 laser desorption linear TOF 
mass spectrometer with a 2-m flight tube described 
previously [21]. The spectrometer was modified to 
incorporate a 24 sample loading system with a two 
stage acceleration region. Ions were accelerated to a 
total potential of 30 kV. Laser desorption was per- 
formed by using the 355-nm focused output of a fre- 
quency tripled Lumonics model HY 400 Nd:YAG laser 
(Lumonics, Ottawa, Ontario, Canada). The laser pulse 
width was 10 ns and the pulse frequency was 10 Hz. 
All spectra were collected at analyte ion threshold 
laser irradiances. The laser energies used with 2,5- 
DHBA and 3-HPA were roughly 10-20 mJ/pulse and 
50-60 mJ/pulse, respectively. Signals were detected 
by a 20 stage focused mesh electron multiplier (model 
MMI-ISG, Becton-Dickinson, Towson, MD). 
Solid matrices employed in MALDI tend to form 
inhomogenous crystals, causing mass spectra to vary 
substantially from one spot to another for a given 
sample. In the present study multiple spectra were 
acquired for every sample at different sites to confirm 
the results obtained. Unless indicated otherwise, 10- 
pmol samples were employed in all studies. Mass 
calibration was performed by using bovine pancreas 
insulin (Sigma Chemical Co., St. Louis, MO) and ma- 
trix as internal calibrants. All oligonucleotide samples 
were also MALDI analyzed by using the matrix 3-HPA, 
which exhibits little or no oligonucleotide fragmenta- 
tion in the linear mode, to rule out the possibility of 
oligodeoxynucleotide degradation during sample stor- 
age (data not shown). Control laser desorption experi- 
ments without a MALDI matrix performed on all 5-mer 
oligonucleotides used in this study did not produce 
any detectable ion signals, confirming that the MALDI 
process was operative in these experiments. 
Results and Discussion 
UV-MALDI analysis of short oligonucleotides (_< 5 
bases) in negative-ion mode by using the matrix 2,5- 
DHBA generally shows little or no fragmentation. Fig- 
ure 2a and b displays spectra obtained for d(TAGGT) 
in 2,5-DHBA in both negative- and positive-ion modes, 
respectively. Whereas in negative-ion mode no frag- 
mentation is evident, a substantial mount of fragmen- 
tation is evident in positive-ion mode. In addition, the 
analyte signal obtained in negative-ion mode has 
higher intensity and resolution than the signal ob- 
tained in positive-ion mode. These striking differences 
were hypothesized to result from differences in the 
nature and stability of the positive and negative ions 
formed during the desorption/ionization process. 
In positive-ion mode, the major fragmentation prod- 
uct observed from d(TAGGT) corresponds to the [a 3- 
G] + ion (nomenclature for product ions is adopted 
from McLuckey et al. [22] and MacLafferty and co- 
workers [23] with a and w corresponding, respectively, 
to the 5' and 3' end fragmentation products generated 
from 3' C-O bond cleavage; M designates the analyte 
molecule; negative- and positive-ion fragment peaks 
correspond to deprotonated and protonated species, 
5' TAGGT 3' in 2,5-DHBA I [ M-HI 
L 
A: negative-ion mode 
B: positive-ion mode 
~ [a3-G] + [M+H] + 
I I I I I I - -  
600 600 1000 1200 1400 1600 
M/Z 
F igure  2 .  UV-MALDI mass pectra of d(TAGGT) (MW 1518.2 u) 
by using 2,5-DHBA as the matrix obtained in (a) negative-ion 
and (b) positive-ion modes. Both spectra re plotted on the same 
intensity scale. 
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respectively). Minor fragment peaks corresponding to
[w2] +, [a4-2G] +, [a4-G] +, and [M-G] + are also ob- 
served. These fragment peaks are consistent with a 
proposed fragmentation pathway [9-11] in which base 
protonation i tiates base loss, which leads to cleavage 
at the corresponding 3' C-O bond of the phosphotodi- 
ester backbone. The observation that the majority of 
fragment ions are from the 5' terminus is also consis- 
tent, because in the proposed fragmentation pathway a
positive charge is generated on the 5' end fragmenta- 
tion products [9]. The peak shapes of the d(TAGGT) 
positive-ion fragments are notably asymmetric, show- 
ing a sharp onset on the low mass side with tailing to 
the high mass side. Previous tudies [9] suggested that 
such peak shapes are caused by both prompt and 
delayed fragmentation i  the source region. 
The behavior of polythymidilic acids was investi- 
gated in both positive- and negative-ion modes. Re- 
sults from this study support he hypothesis that nu- 
cleobase protonation is the mechanism of positive ion 
formation in the MALDI process. Figure 3a and b 
shows the negative- and positive-ion spectra of the 
oligonucleotide d(T)12 plotted, respectively, on the 
same intensity scale so that ionization efficiencies in 
both ion modes can be readily compared. Interestingly, 
in contrast to the negative-ion spectrum, where a high 
intensity and high resolution intact [M - HI- deproto- 
nated analyte peak is observed, a much reduced proto- 
nated analyte signal is detected in positive-ion mode. 
Similar results were obtained for d(T) s and other poly- 
thymidilic acids. The possibility that instrumental fac- 
tors are the cause of this difference in signal intensities 
obtained in positive-ion versus negative-ion mode may 
be eliminated as comparable signal intensities are ob- 
tained in both modes when fragmentation-resistant 
samples uch as poly dTs containing suitable protona- 
tion sites (see subsequent text) are analyzed. Schneider 
and Chait [7] and Kirpekar et al. [11] also reported 
suppressed polythymidilic acid signals in positive-ion 
mode. The reduced ability of polythymidilic acids to 
form protonated species in positive-ion mode suggests 
that a suitable protonation site is lacking in these 
samples. Whereas d(T) s processes the same 
sugar-phosphate backbone as d(TAGGT), which is 
readily analyzed in positive-ion mode (shown in Fig- 
ure 2b), one can infer that the protonation site resides 
on the nucleobase. The nucleobase thymine is known 
to have a substantially lower proton affinity than the 
other three nucleobases. Recently measured proton 
affinities for the nucleobases guanine, adenine, cyto- 
sine, and thymine are 227.4, 224.2, 225.9, and 209.0 
kcal/mol, respectively, and are 234.4, 233.6, 233.2, and 
224.9 kcal/mol for the corresponding deoxyribonucle- 
oside monophosphates [24]. Though a proton affinity 
of 224.9 kcal/mol for thymidine monophosphate ap- 
pears large, the equilibrium distribution of protons in 
the MALDI plume depends on the relative proton 
affinities of the analyte and matrix (or matrix-related 
species), rather than on their absolute proton affinities. 
Thus the > 8-kcal/mol difference between thymidine 
and the other nucleosides may account for the critical 
difference in their behaviors. A more detailed analysis 
of the role of matrix and nucleoside proton affinities in 
the MALDI ionization process is presented elsewhere 
[15]. 
The low proton affinity of thymine nucleobase also 
provides an explanation for the observed lack of frag- 
mentation when polythymidilic acids are analyzed [ 18]. 
The proton affinities of the nucleobases guanine, ade- 
nine, and cytosine increase comparable amounts, 
7.0-9.4 kcal/mol, when incorporated into deoxyri- 
bonucleoside monophosphates. However, for thymine, 
the increase is substanially larger, 15.9 kcal/mol. This 
substantial difference in proton affinity increases can 
be explained by a change of the protonation site in the 
nucleotide. Based on the measured and calculated pro- 
ton affinities of ethyl isopropyl phosphate and triethyl 
phosphate, Rodgers et al. [25] estimated the gas-phase 
proton affinity of the phosphate group in dinucleotides 
to be 220-225 kcal/mol. The similarity in proton 
affinities of phosphate groups and thymidine 
monophosphates indicates that thymidine nucleotides 
are protonated on the phosphate moiety rather than on 
the thymine nucleobase. Therefore, homopolymers of
thymidine are resistant o fragmentation because nu- 
cleobase protonation, which initiates fragmentation, is 
precluded. 
The foregoing hypothesis, which explains the re- 
duced analyte signal for thymidine homopolymer in 
positive-ion mode, suggests that inclusion of a suitable 
protonation site in these oligonucleotides would result 
in ion signals. Although the nucleosides dA, dC, and 
dG provide protonation sites, they are also susceptible 
to fragmentation as shown in Figure 2b. To preclude 
fragmentation, a nucleoside analog that possesses a 
protonation site that does not result in fragmentation is 
A: negative-ion mode [M-H]- 
d(~)12 
~' B': pos i t ive- ion mode 
d(r)12 [~+H] + 
I 
C: pos i t ive- ion mode 
d(T4T* T7 ) [M +HI + 
d(T4cATa T v) ]+ 
I I I I 
1000 2000 3000 4000 
M/z 
Figure 3. UV-MALDI  mass spectra obtained by using 2,5-DHBA 
as the matrix. (a) d(T)12 (MW 2980.30 u) in negative-ion mode; 
(b) d(T)12 in positive-ion mode; (c) d(T4T*T 7) (MW 3686.86 u) in 
positive-ion mode; (d) d(T4C AraT 7) (MW 3589.75 u) in positive-ion 
mode. All spectra are plotted on the same intensity scale. 
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required. Figure 3c and d shows positive-ion spectra 
obtained by using oligodeoxynucleotides T4NT 7 incor- 
porating such nucleoside analogs, where N represents 
either thymidine modified at the C-5 position of the 
nucleobase with a but-2-enoic acid (2-amino-ethyl)- 
amide (dT*) or arabinose-cytidine (C Ara) (Figure 1). 
AM1 calculations estimate a proton affinity (PA) for 
but-2-enoic acid (2-amino-ethyl)-amide of 225 
kcal/mol, assuming protonation at the terminal amine. 
Because the proton is most likely associated jointly 
with both the terminal and the internal amines in this 
molecule, this value for the proton affinity is probably 
underestimated (AM1 calculations tend to yield PAs 
for bifunctional bases that are low by 6.8-14.4 kcal/mol 
[26] compared to measured values). The modified 
thymidine provides a protonation site on the thymine 
nucleobase that does not weaken the N-glycosidic link- 
age upon protonation. The reason for the increased 
stability of the Ara-C derivative is presumed to be 
similar to that for the increased stability of RNA 
[27-29]. The substitution of the C-2' hydrogen by a 
hydroxyl group appears to stabilize the N-glycosidic 
bond resulting in increased ion stabilities. For both the 
modified thymidine and cytidine oligonucleotides an 
intense protonated analyte peak [M + H] + is observed 
and no fragment peaks are evident, consistent with the 
hypothesized fragmentation mechanism. Signal inten- 
sities in both positive- and negative-ion modes are 
comparable for these modified oligonucleotides (nega- 
tive-ion spectra not shown). A noteworthy observation 
is that no doubly protonated analyte peaks are evident 
in the positive-ion spectra for these oligonucleotides 
containing a single nucleoside analog. However, if 
multiple C Ar~ or dT* groups are included in the 
oligonucleotide, doubly protonated analyte peaks are 
observable (spectra not shown). This result is expected 
given that only a single protonation site is present in 
the T4NT7 oligonucleotide samples. 
The work presented herein provides a framework 
for understanding the nature of the ions formed in the 
MALDI analysis of oligonucleotides. To further test 
this understanding, more complex samples were ana- 
lyzed. Figure 4a and b shows spectra for the oligonu- 
cleotide d(T4C4T 7) obtained in negative- and positive- 
ion modes, respectively. In a previous study [9], the 
negative-ion spectrum of this sample was interpreted 
in terms of a fragmentation scheme based on the 
assumption that fragment ions were produced via se- 
rial cleavages at distinct cleavage sites. Hence, the total 
amount of each fragment observed is the sum of that 
generated at each cleavage reaction minus the amount 
consumed in subsequent reactions. The initial frag- 
mentation for dT4N4T 7 (N = A, C, or G) yields the 3' 
end fragment ions w 7, w 8, w 9, and Wlo. The fragments 
w s, w 9, and Wlo can then undergo secondary fragmen- 
tation reactions to generate more WT, w8, and w 9 
fragment ions. These multiple serial cleavage vents 
ultimately generate the stable fragment ion WT, which 
no longer contains any cleavage sites. These serial 
~t 
w71[~0] - wi~T4C4gTa~i)v¢-i . . . .  de [M C] [M-HI- 
[ 9 [,~1o I-  
B: positive-ion mode 
d(T4C4T7 ) 
z [M+2H]2+ [M+H]+ 
C: posRive-ion mode 
d(T4C4T3T'5 ) 
I~7]+ IM+HF 
[M-c]  + 
I I ~ I I I 
2000 2500 3000 3500 4000 4500 5000 
M/Z 
Figure 4. UV-MALDI mass pectra obtained by using 2,5-DHBA 
as the matrix. (a) d(T4C4T 7) (MW 4441.41 u) in negative-ion 
mode; (b) d(T4C4T 7) in positive-ion mode; (c) d(T4C4T3T*T 3)
(MW 4539.51 u) in positive-ion mode. All spectra re plotted on 
the same intensity scale. 
cleavage vents give rise to a characteristic pattern of 
decreasing intensities for the 3' end fragment peaks w 7 
to wl0 (Figure 4a). 
Whereas the negative-ion spectrum shown in Figure 
4a is essentially identical to that described and inter- 
preted previously [9], the positive-ion spectrum is 
markedly different. In contrast to the negative-ion 
spectrum where four 3' end fragments are clearly 
evident, the positive-ion spectrum shows negligible 
amounts of 3' end fragments and exhibits only two 
major peaks: one corresponding to the protonated ana- 
lyte and the other to protonated analyte lacking a 
single cytosine. The intensities of these two peaks in 
positive-ion mode are much lower than those of the 
corresponding peaks obtained in negative-ion mode. 
Similar results were obtained for the oligonucleotides 
d(T4CT 7) and (T4C2T 7) (data not shown). 
These striking differences in the positive- and nega- 
tive-ion spectra raise an interesting issue. If fragmenta- 
tion propensity is greater in positive-ion than in nega- 
tive-ion mode, why are 3' end fragments from the 
d(T4C4T 7) absent in the positive-ion spectrum? The 
proposed explanation is based on results presented 
earlier in this article and those of Zhu et al. [9]. It was 
hypothesized that low intensities of the residual proto- 
nated analyte peaks in Figure 4b resulted from exten- 
sive fragmentation i positive-ion mode. Detectable 
fragment peaks of w8, w 9, and wlo were absent from 
the spectrum because these fragments underwent ex- 
tensive serial fragmentation to ultimately form w 7 
fragments. The absence of w7 signal is attributed to the 
lack of a suitable protonation site in this homoth- 
ymidilic dT 7 fragment, just as was shown previously 
for d(T)12 (Figure 3). To test this hypothesis, a protona- 
tion site was incorporated into the w 7 fragment. The 
modified nucleoside dT* was used for this purpose; 
the protonation site in this molecule is separated from 
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the heterocyclic ring by several atoms, thus providing 
a high proton affinity site for protonation without 
destabilizing the N-glycosidic bond. 
Figure 4c shows the results obtained by using the 
modified oligonucleotide d(T4C4T3T*T3). This sample 
produces a prominent w 7 peak in the mass spectrum, 
as predicted, providing strong support for the hypoth- 
esized mechanism. The reason that only the 3' end 
fragmentation product w 7 is observed here is because 
dT* is only present in the 3' end of this modified 
oligonucleotide. Similar results were obtained for the 
oligonucleotides d(T4CT3T*T 3) and d(T4C 2T3T*T3) (data 
not shown). 
The behaviors of these oligonucleotides in different 
ion modes were further investigated by using modi- 
fied oligonucleotides d(TBT*CT3T*T3), d(T3T*T3CT*T3) , 
d(T6T*CT*T3), and d(TBT*CT*T6). Figure 5a-c shows 
MALDI spectra obtained for the oligonucleotide 
d(T4CT 7) in both negative- and positive-ion modes and 
for the modified oligonucleotide d(T3T*CTBT*T 3) in 
positive-ion mode by using the matrix 2,5-DHBA. The 
negative-ion spectrum of d(TgT*CT3T*T 3) (data not 
shown) is similar to that of d(T4CT 7) shown in Figure 
5a. No base loss peak is evident in the positive-ion 
spectrum of d(T4CT7), which is also attributed to loss 
of a suitable protonation site in this homothymidilic 
acid fragment d(T4CT7)-[C] (the protonated analyte 
lacking cytosine). In contrast, both 5' and 3' end frag- 
ment ions and protonated analyte lacking the cytosine 
nucleobase are evident in the positive-ion spectrum of 
d(TgT*CTBT*T 3) (Figure 5c). This result is expected 
because dT* is present in both the 5' an 3' ends of the 
sample. Similar spectra were obtained for 
d(T3T*T3CT*T3), d(T6T*CT*T3), and d(T3T*CT*T56) 
(data not shown). No substantial difference in frag- 
ment ion signal intensities is observed when the rela- 
tive location of dT* is varied in the sequences of these 
A: negative-ion mode 
d(T4CTT) - ~ [M-HI 
- [~] [t [~-c]  [ M-2R]~- ~ / l  
B: positive-ion mode 
d(T4CT 7) [M+H] + 
____ . J L  ~, ~ 
C: positive-ion mode 
d(TsT" CT3T" T3 ) 
[%-c] + [~7] + 
I I 
1000 15~00 2000 2500 
M/Z 
I 
3000 
[M+H] ÷ 
[M-C]+~ 
I I 
3500 4000 
Figure 5. UV-MALDI mass pectra obtained by using 2,5-DHBA 
as the matrix. (a) d(T4CT 7) (MW 3573.8 u) in negative-ion mode; 
(b) d(T4CT 7) in positive-ion mode; (c) d(T3T*CT3T*T 3) (MW 3770 
u) in positive-ion-mode. All spectra re plotted on the same 
intensity scale. 
modified samples. Interestingly, although no signifi- 
cant fragment ion peaks are shown in Figures 4b and 
5b, the preceding results suggest hat in fact substan- 
tial fragmentation is occurring for these samples, but 
that absence of a suitable protonation site precludes 
detection of the resulting fragments. 
A question also arises as to why in the positive-ion 
spectra fragment peaks resulting from single cleavage 
events are apparent for d(TAGGT) (such as the [a4-G] + 
peak) and not for d(T4C4T7). We attribute this observa- 
tion to the fact that longer oligonucleotides are suscep- 
tible to more fragmentation because they remain longer 
in the source region. A 15-mer oligonucleotide spends 
about 70% more time in the source region than a 
5-mer. In experiments not shown here [30], oligonu- 
cleotides underwent substantially more fragmentation 
when the amount of time they spend in the source 
region was increased by decreasing the acceleration 
voltage. A gradual increase in fragmentation with in- 
creasing size of oligomers is also observed for ho- 
mopolymers of deoxyguanosine, deoxyadenosine, and 
deoxycytidine [31]. 
Conclusions 
Four major conclusions can be drawn from this work. 
First, the fragmentation of positive ions of oligonu- 
cleotides in UV-MALDI is greatly exacerbated relative 
to negative ions. This reflects the fundamental premise 
that the nucleobase protonation essential to positive-ion 
formation in the MALDI process also initiates base 
loss, which leads to backbone cleavage of the DNA. 
Second, polythymidilic acids are not ionized efficiently 
in positive-ion mode MALDI, probably because of the 
low proton affinity of the thymine nucleobase. Third, 
introduction of a suitable fragmentation-resistant pro-
tonation site into an oligonucleotide can permit posi- 
tive-ion formation and detection without concomitant 
fragmentation. Finally, fragmentation products may in 
some cases be absent from the spectra even though 
extensive fragmentation is occurring. Elucidating the 
ionization and fragmentation processes of oligonu- 
cleotides during MALDI provides us with a founda- 
tion from which to improve its utility for the analysis 
of complex polynucleotide samples. 
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